These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2144391)

  • 1. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.
    Wahl M; Hermodsson S
    Scand J Infect Dis; 1987; 19(6):617-21. PubMed ID: 3441747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel--a preliminary report.
    Prasetya E; Linggadjaja W; Syambali R; Kusumo S; Dharmesetyawan DF; Rahardja U
    Ann Acad Med Singap; 1986 Apr; 15(2):153-7. PubMed ID: 2944466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal hepatitis B vaccination in thalassaemia.
    Leonardi S; Leggio T; Sciacca A; Di Gregorio F; Musumeci S
    Arch Dis Child; 1990 May; 65(5):527-9. PubMed ID: 2141464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.
    Mok Q; Underhill G; Wonke B; Aldouri M; Kelsey M; Jefferies D
    Arch Dis Child; 1989 Apr; 64(4):535-40. PubMed ID: 2526622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal hepatitis B vaccination.
    Rivey MP; Peterson J
    DICP; 1991 Jun; 25(6):628-34. PubMed ID: 1831579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped.
    Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S
    J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal hepatitis B vaccination in a 300-bed primary care hospital: experience with a recombinant vaccine in a four-dose schedule.
    McMaster KR; Roper JK; Carter JB
    Am J Infect Control; 1993 Dec; 21(6):283-8. PubMed ID: 8122799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization.
    McKinney WP; Russler SK; Horowitz MM; Battiola RJ; Lee MB
    Infect Control Hosp Epidemiol; 1991 Apr; 12(4):226-30. PubMed ID: 1829469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
    Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal hepatitis B vaccination in an abbreviated schedule.
    Halsey NA; Reppert EJ; Margolis HS; Francis DP; Fields HA
    Vaccine; 1986 Dec; 4(4):228-32. PubMed ID: 3541426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients.
    Ono K; Kashiwagi S
    Nephron; 1991; 58(1):47-51. PubMed ID: 1830374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.
    Redfield RR; Innis BL; Scott RM; Cannon HG; Bancroft WH
    JAMA; 1985 Dec; 254(22):3203-6. PubMed ID: 2933535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients.
    Arbizu EA; Marugán RB; Grijalba JY; Serrano PL; Grande LG; Del Campo Terrón S
    Vaccine; 2003 Jun; 21(21-22):2747-50. PubMed ID: 12798613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials of intradermal hepatitis B vaccines in Gambian children.
    Whittle HC; Lamb WH; Ryder RW
    Ann Trop Paediatr; 1987 Mar; 7(1):6-9. PubMed ID: 2439007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.